UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006464
Receipt No. R000007668
Scientific Title A translational study of "Randomized phase II trial evaluating trastuzumab + capecitabine (HX) or lapatinib + capecitabine (LX) in HER2-positive metastatic breast cancer patients previously treated with trastuzumab and taxanes."
Date of disclosure of the study information 2011/10/04
Last modified on 2018/09/18 16:03:56

No. Disposal Last modified on Item of update
1 Insert 2011/10/04 09:24:02
2 Update 2012/05/23 10:39:30 Recruitment status
3 Update 2014/02/12 14:00:10 Target sample size
4 Update 2014/03/12 15:03:07 Email
Email
Tel1
Email1
5 Update 2015/01/07 13:09:47 Recruitment status
6 Update 2018/04/09 09:23:58 Recruitment status
7 Update 2018/09/18 16:03:56 Recruitment status
Publication of results
URL related to results and publications


Contact us.